{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:05:29Z","timestamp":1788465929647,"version":"build-2803163510"},"reference-count":31,"publisher":"AOSIS","issue":"1","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Background:\u00a0The success rates for treating drug-resistant tuberculosis (DR-TB) in programmatic settings have been unsatisfactory. By identifying the factors that predict treatment outcomes, we can implement effective corrective measures that will significantly enhance patient management and improve results for those with DR-TB.\nAim:\u00a0This study aimed to investigate predictive factors influencing treatment outcomes among DR-TB patients, focusing on the combined effects of body mass index (BMI), human immunodeficiency virus (HIV) status, comorbidities, socioeconomic factors, substance use and DR-TB type.\nSetting:\u00a0The study was conducted in rural Eastern Cape, South Africa.\nMethods:\u00a0This retrospective cohort study was designed to utilise logistic regression models on data from 200 patient medical records. We examined variables including BMI, HIV co-infection, comorbidities (e.g. diabetes, hypertension), income, substance use and DR-TB classifications (multidrug-resistant, rifampicin-resistant, pre-extensively drug-resistant, extensively drug-resistant).\nResults:\u00a0Key findings indicate a weak association between lower BMI and reduced treatment success (odds ratio [OR]: 0.92, 95% confidence interval [CI]: 0.81\u20131.05). HIV-positive status was marginally associated with lower treatment success (OR: 0.89, 95% CI: 0.75\u20131.12), while income level and substance use emerged as stronger predictors (e.g. substance use OR: 0.72, 95% CI: 0.60\u20130.88). Among DR-TB types, extensively drug-resistant tuberculosis patients exhibited the poorest outcomes (OR: 0.55, 95% CI: 0.40\u20130.75). The multivariate model achieved an accuracy of 63.1%, suggesting limited predictive power of BMI and HIV alone and highlighting the significant influence of comorbidities, socioeconomic status and behavioural factors.\nConclusion:\u00a0These findings underscore the importance of a multidimensional approach in improving DR-TB treatment outcomes through tailored clinical and social interventions.\nContribution:\u00a0The study noted limited connections between DR-TB and various comorbidities. It highlights the necessity of managing coexisting conditions in DR-TB patients because of their significant impact on treatment outcomes. Customised interventions are essential for those with severe or complex comorbidities.<\/jats:p>","DOI":"10.4102\/phcfm.v17i1.4953","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T14:34:30Z","timestamp":1759242870000},"update-policy":"https:\/\/doi.org\/10.4102\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Predictors of drug-resistant TB outcomes: Body mass index, HIV, and comorbidities"],"prefix":"10.4102","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0356-8912","authenticated-orcid":false,"given":"Ntandazo","family":"Dlatu","sequence":"first","affiliation":[{"name":"Walter Sisulu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7308-4239","authenticated-orcid":false,"given":"Lindiwe","family":"Faye","sequence":"additional","affiliation":[{"name":"Walter Sisulu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0732-4978","authenticated-orcid":false,"given":"Ncomeka","family":"Sineke","sequence":"additional","affiliation":[{"name":"Walter Sisulu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1329-3864","authenticated-orcid":false,"given":"Teke","family":"Apalata","sequence":"additional","affiliation":[{"name":"Walter Sisulu University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2580","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Reichler MR, Khan A, Sterling TR, et al. Risk and timing of tuberculosis among close contacts of persons with infectious tuberculosis. J Infect Dis. 2018;218(6):1000\u20131008. https:\/\/doi.org\/10.1093\/infdis\/jiy265","DOI":"10.1093\/infdis\/jiy265"},{"key":"ref1","unstructured":"World Health Organization (WHO). WHO global tuberculosis report 2023 [homepage on the Internet]. Geneva: World Health Organization; 2023 [cited 2025 Jan 15]. Available from: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2023"},{"key":"ref2","unstructured":"South African National Department of Health. Implementation of shorter, all-oral regimens for multidrug-resistant TB [homepage on the Internet]. Pretoria: Department of Health; 2022 [cited 2025 Feb 12]. Available from: https:\/\/www.health.gov.za"},{"key":"ref3","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4: Treatment \u2013 Drug-resistant tuberculosis treatment, 2020 update [homepage on the Internet]. Geneva: World Health Organization; 2021 [cited 2025 Jan 20]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240007048"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Naidoo K, Perumal R, Cox H, et al. The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis \u2013 Lessons from the South African experience. Lancet Infect Dis. 2024;24(9):e559\u2013e575. https:\/\/doi.org\/10.1016\/S1473-3099(24)00144-0","DOI":"10.1016\/S1473-3099(24)00144-0"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Dheda K, Gumbo T, Maartens G, et al. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respir Med. 2017;5(4):291\u2013360. https:\/\/doi.org\/10.1016\/S2213-2600(17)30079-6","DOI":"10.1016\/S2213-2600(17)30079-6"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Smith J, Doe A, Lee R. The impact of diabetes on tuberculosis treatment outcomes: A systematic review. Int J Tuberc Lung Dis. 2018;22(3):245\u2013252. https:\/\/doi.org\/10.5588\/ijtld.17.0492","DOI":"10.5588\/ijtld.17.0492"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Naidoo K, Yende-Zuma N, Augustine S. A retrospective cohort study of body mass index and survival in HIV infected patients with and without TB co-infection. Infect Dis Poverty. 2018;7:1\u20136. https:\/\/doi.org\/10.1186\/s40249-018-0418-3","DOI":"10.1186\/s40249-018-0418-3"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Faye LM, Hosu MC, Iruedo J, et al. Treatment outcomes and associated factors among tuberculosis patients from selected rural Eastern Cape hospitals: An ambidirectional study. Trop Med Infect Dis. 2023;8(6):315. https:\/\/doi.org\/10.3390\/tropicalmed8060315","DOI":"10.3390\/tropicalmed8060315"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Campbell JR, Chan ED, Falzon D, et al. Low body mass index at treatment initiation and rifampicin-resistant tuberculosis treatment outcomes: An individual participant data meta-analysis. Clin Infect Dis. 2022;75(12):2201\u20132210. https:\/\/doi.org\/10.1093\/cid\/ciac322","DOI":"10.1093\/cid\/ciac322"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Mitra DK, Mistry SK, Afsana K, Rahman M. Demographic, socio-economic and lifestyle determinants of under-and over-nutrition among Bangladeshi adult population: Results from a large cross-sectional study. J Epidemiol Glob Health. 2018;8(3):134\u2013142. https:\/\/doi.org\/10.1016\/j.jegh.2018.03.002","DOI":"10.1016\/j.jegh.2018.03.002"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Lee JY, Myong JP, Kim Y, et al. Identifying predictors of unfavorable treatment outcomes in tuberculosis patients. Int J Environ Res Public Health. 2024;21(11):1454. https:\/\/doi.org\/10.3390\/ijerph21111454","DOI":"10.3390\/ijerph21111454"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Pasha I, Lakkad A. Clinical characteristics and outcome predictors in drug-resistant tuberculosis: A comprehensive analysis. Adv Res. 2024;25(5):67\u201379. https:\/\/doi.org\/10.9734\/air\/2024\/v25i51138","DOI":"10.9734\/air\/2024\/v25i51138"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Nidoi J, Muttamba W, Walusimbi S, et al. Impact of socio-economic factors on tuberculosis treatment outcomes in north-eastern Uganda: A mixed methods study. BMC Public Health. 2021;21(1):2167. https:\/\/doi.org\/10.1186\/s12889-021-12056-1","DOI":"10.1186\/s12889-021-12056-1"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Peltzer K. Tuberculosis non-communicable disease comorbidity and multimorbidity in public primary care patients in South Africa. Afr J Prim Health Care Fam Med. 2018;10:1\u20136. https:\/\/doi.org\/10.4102\/phcfm.v10i1.1651","DOI":"10.4102\/phcfm.v10i1.1651"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Pradipta IS, Forsman LD, Bruchfeld J, Hak E, Alffenaar JW. Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis. J Infect. 2018;77:469\u2013478. https:\/\/doi.org\/10.1016\/j.jinf.2018.10.004","DOI":"10.1016\/j.jinf.2018.10.004"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Dheda K, Mirzayev F, Cirillo DM, et al. Multidrug-resistant tuberculosis. Nat Rev Dis Primers. 2024;10:22. https:\/\/doi.org\/10.1038\/s41572-024-00504-2","DOI":"10.1038\/s41572-024-00504-2"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Noubiap JJ, Nansseu JRN, Endomba FT, Kaze AD, Nkeck JR, Bigna JJ. The effects of diabetes on tuberculosis treatment outcomes: An updated systematic review and meta-analysis. Int J Tuberc Lung Dis. 2019;23(7):783\u2013796. https:\/\/doi.org\/10.5588\/ijtld.18.0433","DOI":"10.5588\/ijtld.18.0433"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Mohanty SR, Mohanty LK. Comorbidity and tuberculosis: A study of prevalence and impact on disease progression. Int J Life Sci Biotechnol Pharma Res. 2024;13(6):347\u2013351. https:\/\/doi.org\/10.69605\/ijlbpr_13.6.2024.65","DOI":"10.69605\/ijlbpr_13.6.2024.65"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Chibasa M, Kazonga E, Chilinya M, et al. Factors associated with poor treatment outcomes in newly diagnosed tuberculosis patients in sub-Sahara Africa: A systematic review. East Afr Scholars J Med Sci. 2024;7(10):409\u2013420. https:\/\/doi.org\/10.36349\/easms.2024.v07i10.005","DOI":"10.36349\/easms.2024.v07i10.005"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Ketema DB, Alene M, Assemie MA, Yismaw L, Merid MW. Risk factors for mortality among drug-resistant tuberculosis patients registered for drug-resistant treatment in Amhara region, Ethiopia: A historical cohort study. Arch Pub Health. 2020;78:69. https:\/\/doi.org\/10.1186\/s13690-020-00448-5","DOI":"10.1186\/s13690-020-00448-5"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Byrne AL, Marais BJ, Mitnick CD, Lecca L, Marks GB. Tuberculosis and chronic respiratory disease: A systematic review. Int J Infect Dis. 2015;32:138\u2013146. https:\/\/doi.org\/10.1016\/j.ijid.2014.12.016","DOI":"10.1016\/j.ijid.2014.12.016"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Yener\u00e7a\u011f FN, Ayd\u0131n F. Factors affecting treatment outcomes for tuberculosis patients: A retrospective cohort study. Harran \u00dcniv T\u00fdp Fak Derg [J Harran Univ Med Fac]. 2024;21(2):306\u2013313. https:\/\/doi.org\/10.35440\/hutfd.1446494","DOI":"10.35440\/hutfd.1446494"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Ahmed A, Weldegebreal F, Tebeje F, Dessie Y. Treatment outcomes of tuberculosis cases by HIV status in Haramaya General Hospital, Ethiopia: A retrospective cross-sectional study. Medicine. 2024;103(18):e38034. https:\/\/doi.org\/10.1097\/md.0000000000038034","DOI":"10.1097\/MD.0000000000038034"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Sambarey A, Smith K, Chung C, et al. Integrative analysis of multimodal patient data identifies personalized predictors of tuberculosis treatment prognosis. Iscience. 2024;27(2):109025. https:\/\/doi.org\/10.1016\/j.isci.2024.109025","DOI":"10.1016\/j.isci.2024.109025"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Alsaiari SA, Shamlan AM, Al Fataih JA, et al. Health disparities in general medicine: A systematic review of socioeconomic and demographic influences. J Eco Hum. 2024;3(7):4603\u20134612. https:\/\/doi.org\/10.62754\/joe.v3i7.4572","DOI":"10.62754\/joe.v3i7.4572"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Sharmake A. Healthcare disparities among socioeconomic groups. Int J Hum Soc Sci. 2024;3(1):1\u201313. https:\/\/doi.org\/10.47941\/ijhss.1889","DOI":"10.47941\/ijhss.1889"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Hussain Z, Kashif HM, Sheikh TR, Memon SP. Examine how socio-economic inequalities and access to healthcare affect hospitalization rates and patient outcomes in rural and urban hospitals. Rev Appl Manag Soc Sci. 2025;8(1):169\u2013181. https:\/\/doi.org\/10.47067\/ramss.v8i1","DOI":"10.47067\/ramss.v8i1.447"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Domb BG, McCarroll TR. Editorial commentary: Socioeconomic disparities in health outcomes: The patient behind the procedure. Arthroscopy. 2025;41(4):950\u2013951. https:\/\/doi.org\/10.1016\/j.arthro.2024.07.001","DOI":"10.1016\/j.arthro.2024.07.001"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Raghav DSV, Padmavathi SM. The role of socioeconomic factors in shaping health outcomes among vulnerable populations. S East Eur J Public Health. 2024;XXV(S1):1422\u20131432. https:\/\/doi.org\/10.70135\/seejph.vi.2086","DOI":"10.70135\/seejph.vi.2086"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Cannon LL, Oladimeji KE, Goon DT. Socio-economic drivers of drug-resistant tuberculosis in Africa: A scoping review. BMC Public Health. 2021;21(1):488. https:\/\/doi.org\/10.1186\/s12889-021-10267-0","DOI":"10.1186\/s12889-021-10267-0"}],"container-title":["African Journal of Primary Health Care &amp; Family Medicine"],"original-title":[],"link":[{"URL":"https:\/\/phcfm.org\/index.php\/phcfm\/article\/view\/4953\/8705","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T14:34:39Z","timestamp":1759242879000},"score":1,"resource":{"primary":{"URL":"https:\/\/phcfm.org\/index.php\/phcfm\/article\/view\/4953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,6]]}},"URL":"https:\/\/doi.org\/10.4102\/phcfm.v17i1.4953","relation":{},"ISSN":["2071-2928","2071-2936"],"issn-type":[{"value":"2071-2928","type":"print"},{"value":"2071-2936","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"article-number":"a4953"}}